The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| DH | -29.79% | N/A | N/A | -93% |
| S&P | +16.9% | +95.99% | +14.39% | +52% |
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. Its solution offers information on healthcare providers and their activities to help the customers optimize from product development to go-to-market planning, sales, and marketing execution. The company was founded by Jason Kranzt in February 2011 and is headquartered in Framingham, MA.
These two Russell 1000 members know how to grow revenue.
The company doesn't make drugs or devices -- which is part of the appeal.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $60.75M | -4.7% |
| Gross Profit | $37.61M | -8.4% |
| Gross Margin | 61.91% | -2.5% |
| Market Cap | $418.63M | -35.0% |
| Market Cap / Employee | $0.54M | 0.0% |
| Employees | 782 | -5.8% |
| Net Income | -$9.27M | 97.0% |
| EBITDA | $10.84M | 12.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $80.98M | -33.0% |
| Accounts Receivable | $37.51M | -15.1% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $166.75M | -31.7% |
| Short Term Debt | $11.21M | -30.4% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -27.80% | -4.8% |
| Return On Invested Capital | -17.42% | -11.7% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $7.01M | -48.6% |
| Operating Free Cash Flow | $9.30M | -33.7% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 1.02 | 0.94 | 0.74 | 1.32 | 77.21% |
| Price to Sales | 2.03 | 1.87 | 1.31 | 1.70 | -31.62% |
| Price to Tangible Book Value | -1.85 | -1.70 | -1.33 | -2.39 | 100.87% |
| Price to Free Cash Flow TTM | 10.76 | 11.61 | 7.62 | 11.56 | -44.09% |
| Enterprise Value to EBITDA | 47.72 | 44.45 | 61.37 | 47.78 | -45.69% |
| Free Cash Flow Yield | 9.3% | 8.6% | 13.1% | 8.6% | 78.86% |
| Return on Equity | -53.2% | -63.3% | -86.4% | -64.3% | 31.19% |
| Total Debt | $257.19M | $253.11M | $180.61M | $177.96M | -31.61% |
DH earnings call for the period ending June 30, 2022.
DH earnings call for the period ending March 31, 2022.
DH earnings call for the period ending December 31, 2021.
DH earnings call for the period ending September 30, 2021.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
